tm logo

Monitor this mark

View On USPTO

ALIQOPA
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 28 Jul 2023

Last Applicant/ Owned by

Bayer Intellectual Property GmbH

Alfred-Nobel-Str. 50

Monheim am Rhein

DE

40789

Serial Number

86796421 filed on 22nd Oct 2015

Registration Number

5144321 registered on 21st Feb 2017

in the Principal Register

Correspondent Address

Phillip Barengolts

Phillip Barengolts Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP

Suite 2900

Chicago, IL 60606

United States

Filing Basis

1. intent to use

Disclaimer

NO DATA

ALIQOPA

Pharmaceutical preparations for the treatment of cancer

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of cancer

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 86796421

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

Yes

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
17th Dec 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17th Dec 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
17th Dec 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
17th Dec 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28th Jul 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
28th Jul 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
28th Jul 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01st Feb 2023TEAS SECTION 8 & 15 RECEIVED
21st Feb 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14th Feb 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED